$984 Million is the total value of Hikari Power Ltd's 127 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 35.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKA | Buy | BERKSHIRE HATHAWAY INC CLASS Acl a | $232,000,000 | +15.2% | 725 | +1.5% | 23.59% | +6.4% |
JNJ | Buy | JOHNSON & JOHNSON | $37,515,000 | +25.2% | 271,510 | +10.0% | 3.81% | +15.6% |
MMM | Buy | 3M CO | $31,535,000 | +12.7% | 149,660 | +5.2% | 3.21% | +4.1% |
AGN | Buy | ALLERGAN PLCsponsored adr | $29,254,000 | +50.3% | 153,580 | +31.6% | 2.97% | +38.8% |
NSRGY | Buy | NESTLE SAsponsored adr | $18,428,000 | +24.5% | 221,490 | +15.9% | 1.87% | +15.0% |
KHC | Buy | THE KRAFT HEINZ COMPANY | $14,005,000 | +9.7% | 254,130 | +25.0% | 1.42% | +1.3% |
GIS | Buy | GENERAL MILLS,INC | $11,614,000 | +53.5% | 270,600 | +58.2% | 1.18% | +41.8% |
CL | Buy | COLGATE-PALMOLIVE COMPANY | $9,011,000 | +20.2% | 134,590 | +16.3% | 0.92% | +11.0% |
BUD | Buy | ANHEUSER-BUSCH INBEV NVsponsored adr | $8,490,000 | +22.1% | 96,950 | +40.5% | 0.86% | +12.8% |
USB | Buy | US BANCORP | $6,057,000 | +7.3% | 114,700 | +1.6% | 0.62% | -1.0% |
GE | Buy | GENERAL ELECTRIC COMPANY | $5,889,000 | -14.5% | 521,600 | +3.0% | 0.60% | -21.1% |
VDC | Buy | VANGUARD CONSUMER STAPLES ETFetf | $5,689,000 | +60.4% | 40,600 | +53.7% | 0.58% | +48.2% |
SGYPQ | Buy | SYNERGY PHARMACEUTICALS INC | $4,250,000 | +6.2% | 2,500,000 | +8.7% | 0.43% | -2.0% |
MO | Buy | ALTRIA GROUP INC | $2,922,000 | +58.3% | 48,450 | +49.1% | 0.30% | +46.3% |
AKTX | Buy | AKARI THERAPEUTICS PLC | $2,560,000 | +55.5% | 1,000,000 | +18.5% | 0.26% | +43.6% |
ASHR | Buy | DEUTSCHE X-TRACKERS HARVEST CSI 300 CHINA A-SHARES FUNDetf | $2,446,000 | +51.9% | 96,500 | +59.0% | 0.25% | +40.7% |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORPORATION | $1,931,000 | -3.2% | 155,755 | +19.1% | 0.20% | -10.5% |
HDV | Buy | ISHARES CORE HIGH DIVIDEND ETF | $1,675,000 | +272.2% | 18,500 | +249.1% | 0.17% | +240.0% |
VWO | Buy | VANGUARD FTSE EMERGING MARKETS ETF | $1,402,000 | +95.5% | 34,200 | +101.2% | 0.14% | +81.0% |
BK | New | BANK OF NEW YORK MELLON CORP | $1,290,000 | – | 25,300 | +100.0% | 0.13% | – |
OCUL | Buy | OCULAR THERAPEUTIX INC | $826,000 | +53.0% | 120,001 | +50.0% | 0.08% | +42.4% |
SPHS | New | SOPHIRIS BIO INC | $474,000 | – | 170,000 | +100.0% | 0.05% | – |
CBIO | New | CATALYST BIOSCIENCES INC | $323,000 | – | 30,000 | +100.0% | 0.03% | – |
CRVS | New | CORVUS PHARMACEUTICALS INC | $275,000 | – | 32,090 | +100.0% | 0.03% | – |
BRKB | New | BERKSHIRE HATHAWAY INC CLASS Bcl b | $214,000 | – | 1,000 | +100.0% | 0.02% | – |
SESN | New | SESEN BIO INC | $141,000 | – | 65,592 | +100.0% | 0.01% | – |
SBPH | New | SPRING BANK PHARMACEUTICALS | $137,000 | – | 11,336 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Yasumitsu Shigeta #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-10-31
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CARDINAL HEALTH | 39 | Q3 2023 | 40.7% |
WELLS FARGO & CO NEW | 39 | Q3 2023 | 17.8% |
JOHNSON & JOHNSON | 39 | Q3 2023 | 24.8% |
VISA INC CLASS A | 39 | Q3 2023 | 4.1% |
NOVO-NORDISK A S | 39 | Q3 2023 | 4.2% |
EXXON MOBIL CORPORATION | 39 | Q3 2023 | 3.9% |
NESTLE SA | 39 | Q3 2023 | 3.6% |
COCA COLA CO | 39 | Q3 2023 | 6.4% |
INTUITIVE SURGICAL INC | 39 | Q3 2023 | 2.2% |
BECTON DICKINSON & CO | 39 | Q3 2023 | 2.8% |
View Hikari Power Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-08 |
13F-HR | 2024-01-31 |
13F-HR | 2023-10-26 |
13F-HR | 2023-07-26 |
13F-HR | 2023-04-26 |
13F-HR | 2023-01-25 |
13F-HR | 2022-11-01 |
13F-HR/A | 2022-07-22 |
13F-HR | 2022-07-06 |
13F-HR | 2022-04-13 |
View Hikari Power Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.